Generate a tailored SOP for Dr. Michael Harrison. Improve your application with a focused, well-structured draft.
Michael Roger Harrison is an Associate Professor in the Department of Medicine at the Duke Cancer Institute and has been involved in the field since 2011. He completed his M.D. at Tulane University in 2004 and subsequently undertook a residency at Tulane University focusing on medicine from 2004 to 2007. Dr. Harrison's research includes a concentration on Non–Clear Cell Renal Cell Carcinoma and he has contributed to studies such as the ODYSSEY study that explores the management of unclassified rare renal cell carcinoma subtypes. He is active in clinical trials related to advanced papillary renal cell carcinoma and has expressed interest in the advancements of drug combinations showing benefits in treating rare aggressive kidney cancer. His work is pivotal in oncological care, especially concerning genitourinary cancers.
Duke Cancer Institute • Durham, NC
Associate Professor in the Department of Medicine focusing on cancer research.
Department of Biomedical Engineering (MS program)